Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
22.85
-1.05 (-4.41%)
Sep 30, 2026, 11:06 AM EDT - Market open
Apnimed Revenue
Apnimed had revenue of $12.08M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $115.12M. In the year 2025, Apnimed had annual revenue of $38.47M with 380.12% growth.
Revenue (ttm)
$115.12M
Revenue Growth
+380.12%
P/S Ratio
8.64
Revenue / Employee
$1,421,235
Employees
81
Market Cap
951.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.47M | 30.46M | 380.12% |
| Dec 31, 2024 | 8.01M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
APMD News
- 21 days ago - Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 22 days ago - Apnimed Quarterly report: Q2 2026 - Filings
- 22 days ago - Apnimed Earnings release: Q2 2026 - Filings
- 25 days ago - Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Apnimed initiated with an Outperform at Evercore ISI - TheFly
- 5 weeks ago - Apnimed initiated with an Outperform at LifeSci Capital - TheFly